EnteroMedics Inc 4
4 · EnteroMedics Inc · Filed Mar 11, 2015
Insider Transaction Report
Form 4
EnteroMedics IncETRM
KNUDSON MARK B
DirectorChrmn, Pres & CEO
Transactions
- Award
Stock Option (right to buy)
2015-03-09+225,000→ 225,000 totalExercise: $1.11From: 2015-04-09Exp: 2025-03-09→ Common Stock (225,000 underlying)
Holdings
- 25,902
Stock Option (right to buy)
Exercise: $1.90From: 2010-10-29Exp: 2017-10-29→ Common Stock (25,902 underlying) - 57,571(indirect: By Trust)
Common Stock
- 7,915
Stock Option (right to buy)
Exercise: $2.76Exp: 2015-04-27→ Common Stock (7,915 underlying) - 33,432
Stock Option (right to buy)
Exercise: $1.90From: 2010-10-29Exp: 2017-10-29→ Common Stock (33,432 underlying) - 44,131
Stock Option (right to buy)
Exercise: $1.90From: 2010-10-29Exp: 2017-10-29→ Common stock (44,131 underlying) - 20,833
Stock Option (right to buy)
Exercise: $3.78Exp: 2019-11-18→ Common Stock (20,833 underlying) - 350,000
Stock Option (right to buy)
Exercise: $2.58From: 2011-03-16Exp: 2021-02-16→ Common Stock (350,000 underlying) - 350,000
Stock Option (right to buy)
Exercise: $2.67From: 2011-08-12Exp: 2021-07-12→ Common Stock (350,000 underlying) - 1,278,730
Stock Option (right to buy)
Exercise: $1.31From: 2013-06-30Exp: 2013-05-31→ Common Stock (1,278,730 underlying) - 50,472
Stock Option (right to buy)
Exercise: $1.90From: 2010-10-29Exp: 2017-10-29→ Common Stock (50,472 underlying) - 25,000
Warrant (common stock right to buy)
Exercise: $2.19→ Common Stock (25,000 underlying) - 200,000
Stock Option (right to buy)
Exercise: $1.90From: 2012-01-14Exp: 2021-12-14→ Common Stock (200,000 underlying) - 1,292,225
Stock Option (right to buy)
Exercise: $3.35From: 2012-08-10Exp: 2022-07-10→ Common Stock (1,292,225 underlying) - 1,382(indirect: By Trust)
Common Stock
- 3,215(indirect: By Partnership)
Common Stock
- 6,776
Stock Option (right to buy)
Exercise: $2.76Exp: 2016-04-20→ Common Stock (6,776 underlying)
Footnotes (6)
- [F1]Options currently 100% vested.
- [F2]Options vest 33% on date noted and thereafter at 124th per month.
- [F3]Warrant becomes exercisable 181 days from the date of issuance at close of offering.
- [F4]Warrant expires five years from the date it becomes exercisable.
- [F5]Vests in increments of 1/48th per month, beginning the date shown.
- [F6]The exercise price is the closing price on July 10, 2012, the date the board authorized the grants subject to stockholder approval of the increase in the number of shares available for awards under the incentive plan, which was obtained on September 27, 2012.